T1	HMM 92 135	pharmacokinetics of cephalexin monohydrate.
T2	HMM 400 452	pharmacokinetics and pharmacodynamics of cephalexin.
T3	HMM 637 655	Time-concentration
T4	HMM 685 711	pharmacokinetic parameters
T5	HMM 862 1086	percentage of time that serum concentrations remain above the MIC(90) during the dosing interval (T > MIC(90)) for Streptococcus pyogenes and Staphylococcus aureus associated with the pharmacokinetic profiles was calculated.
T6	HMM 1192 1231	C(max), AUC(infinity), t(1/2), or CL/F.
T7	HMM 1232 1238	t(max)
T8	HMM 1331 1353	Suboptimal T > MIC(90)
T9	HMM 1494 1505	T > MIC(90)
T10	HMM 1608 1614	t(max)
T11	HMM 1728 1734	t(max)
